| Literature DB >> 29148148 |
Andre P Lourenço1, Adelino F Leite-Moreira1, Jean-Luc Balligand2, Johann Bauersachs3, Dana Dawson4, Rudolf A de Boer5, Leon J de Windt6, Inês Falcão-Pires1, Ricardo Fontes-Carvalho1, Stefan Franz7, Mauro Giacca8, Denise Hilfiker-Kleiner9, Emilio Hirsch10, Christoph Maack11, Manuel Mayr12, Burkert Pieske13, Thomas Thum14, Carlo G Tocchetti15, Dirk L Brutsaert16, Stephane Heymans17,18,19.
Abstract
As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps in patient management and therapeutic development are badly needed. With the current position paper we seek to update our view on HFpEF as a highly complex systemic syndrome, from risk factors and mechanisms to long-term clinical manifestations. We will revise recent advances in animal model development, experimental set-ups and basic and translational science approaches to HFpEF research, highlighting their drawbacks and advantages. Directions are provided for proper model selection as well as for integrative functional evaluation from the in vivo setting to in vitro cell function testing. Additionally, we address new research challenges that require integration of higher-order inter-organ and inter-cell communication to achieve a full systems biology perspective of HFpEF.Entities:
Keywords: Animal models; Experimental evaluation; Heart failure with preserved ejection fraction; Molecular biology; Myocardial function
Mesh:
Year: 2017 PMID: 29148148 DOI: 10.1002/ejhf.1059
Source DB: PubMed Journal: Eur J Heart Fail ISSN: 1388-9842 Impact factor: 15.534